|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 304.00 INR | +0.51% |
|
-8.74% | -2.06% |
| Capitalization | 2.85TCr 31Cr 26Cr 24Cr 23Cr 43Cr 45Cr 279.18Cr 110.84Cr 1.34TCr 116.19Cr 113.82Cr 4.89TCr | P/E ratio 2024 |
30.3x | P/E ratio 2025 | 27.3x |
|---|---|---|---|---|---|
| Enterprise value | 3.12TCr 34Cr 29Cr 27Cr 25Cr 47Cr 49Cr 305.59Cr 121.32Cr 1.47TCr 127.18Cr 124.58Cr 5.35TCr | EV / Sales 2024 |
2.47x | EV / Sales 2025 | 2.75x |
| Free-Float |
27.61% | Yield 2024 |
0.22% | Yield 2025 | 0.19% |
More valuation ratios
* Estimated data
More news
Last Transcript: SMS Pharmaceuticals Limited
| 1 day | +0.51% | ||
| 1 week | -8.74% | ||
| Current month | -2.06% | ||
| 1 month | -3.57% | ||
| 3 months | +8.21% | ||
| 6 months | +25.52% | ||
| Current year | -2.06% |
| 1 week | 296.85 |  | 332.3 |
| 1 month | 296.85 | | 360 |
| Current year | 296.85 | | 360 |
| 1 year | 176.05 | | 360 |
| 3 years | 54.55 | | 398 |
| 5 years | 54.55 | | 398 |
| 10 years | 24 | | 398 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 65 | 30/08/1990 | |
| Director of Finance/CFO | - | 13/09/2017 | |
Tirumalesh Tumma
CMP | Compliance Officer | - | 16/02/2022 |
| Director | Title | Age | Since |
|---|---|---|---|
| Chairman | 65 | 30/08/1990 | |
| Director/Board Member | 37 | 05/06/2020 | |
| Director/Board Member | 47 | 29/05/2018 |
| Change | 5d. change | 1-year change | 3-years change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +0.51% | -8.74% | +43.92% | +281.67% | 31Cr | |
| -0.14% | -2.22% | -11.00% | +55.52% | 4.28TCr | |
| +2.36% | +3.63% | +17.51% | +124.30% | 3.04TCr | |
| -4.04% | -5.90% | -9.38% | +23.76% | 1.21TCr | |
| -0.37% | +1.60% | -10.83% | +98.51% | 972.59Cr | |
| -0.41% | -6.36% | +62.32% | +32.66% | 789.03Cr | |
| -0.89% | +0.90% | +42.95% | +131.33% | 805.37Cr | |
| -.--% | +0.14% | - | - | 678.76Cr | |
| +1.04% | +1.19% | +43.10% | -21.20% | 671.95Cr | |
| -1.48% | -1.65% | +30.23% | +369.95% | 615.35Cr | |
| Average | -0.34% | -2.52% | +23.20% | +121.83% | 1.31TCr | |
| Weighted average by Cap. | +0.01% | -2.24% | +9.42% | +88.11% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 709.26Cr 7.72Cr 6.57Cr 6.09Cr 5.69Cr 11Cr 11Cr 70Cr 28Cr 334.88Cr 29Cr 28Cr 1.22TCr | 782.75Cr 8.52Cr 7.25Cr 6.72Cr 6.28Cr 12Cr 12Cr 77Cr 30Cr 369.58Cr 32Cr 31Cr 1.34TCr |
| Net income | 50Cr 54.23L 46.12L 42.75L 39.95L 74.48L 78.94L 4.89Cr 1.94Cr 24Cr 2.03Cr 1.99Cr 86Cr | 69Cr 75.25L 64L 59.32L 55.43L 1.03Cr 1.1Cr 6.78Cr 2.69Cr 33Cr 2.82Cr 2.76Cr 118.74Cr |
| Net Debt | 244.65Cr 2.66Cr 2.26Cr 2.1Cr 1.96Cr 3.66Cr 3.88Cr 24Cr 9.52Cr 115.51Cr 9.99Cr 9.78Cr 420.19Cr | 269.27Cr 2.93Cr 2.49Cr 2.31Cr 2.16Cr 4.02Cr 4.27Cr 26Cr 10Cr 127.13Cr 11Cr 11Cr 462.46Cr |
More financial data
* Estimated data
Employees
1,470
Sector
Pharmaceuticals
Calendar
| Date | Price | Change | Volume |
|---|---|---|---|
| 23/26/23 | 304.00 ₹ | +0.51% | 2,06,623 |
| 22/26/22 | 302.45 ₹ | +1.34% | 2,31,389 |
| 21/26/21 | 298.45 ₹ | -3.62% | 4,16,712 |
| 20/26/20 | 309.65 ₹ | -1.48% | 3,36,545 |
| 19/26/19 | 314.30 ₹ | -5.64% | 5,05,029 |
Delayed Quote NSE India S.E., January 23, 2026 at 05:19 pm IST
More quotes
Annual profits - Rate of surprise
- Stock Market
- Equities
- SMSPHARMA Stock
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition